Skip to main content
Clinical Trials/NCT04477434
NCT04477434
Recruiting
Not Applicable

Observatoire National d'ElectroConvulsivoThérapie (ECT)

Centre Hospitalier Henri Laborit30 sites in 1 country2,000 target enrollmentApril 24, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mental Disorders
Sponsor
Centre Hospitalier Henri Laborit
Enrollment
2000
Locations
30
Primary Endpoint
ECT efficiency on patients
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Since the 30s, ECT has been a psychiatric treatment mainly used for drug-resistant depressive illnesses. Clinical studies have shown its therapeutic efficiency compared to standard treatments also in other psychiatric illnesses. Although efficient, ECTs also induce side effects. In France, there is currently no consensus on providing the suitest medical care. It is therefore important to review our nowadays health care models in order to maintain and improve the recommendations of the French National Agency for Accreditation and Evaluation in Health, the last of which date from 1997! Within this context, this project has the dual objective of (1) identifying ECT medical procedure in France and (2) developing research to evaluate and to improve the effectiveness of this treatment.

Registry
clinicaltrials.gov
Start Date
April 24, 2018
End Date
December 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients consecutively referred for ECT.

Exclusion Criteria

  • Not specified

Outcomes

Primary Outcomes

ECT efficiency on patients

Time Frame: 2018-2022

Study Sites (30)

Loading locations...

Similar Trials